Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novo Nordisk Is Already Working on Ozempic 2.0. Here's How to Profit

TheMotleyFool

0 0

Novo Nordisk Is Already Working on Ozempic 2.0. Here's How to Profit: https://g.foolcdn.com/editorial/images/746626/business-people-and-doctors-talking-on-a-meeting-in-hospital.jpg

Up 41% so far this year on hot sales of its drug Ozempic, Novo Nordisk (NYSE: NVO) isn't wasting any time in teeing up a few attempts at minting its next blockbuster. Ozempic 2.0 is already in the works, and there's no chance that it'll give up if there's a setback.

But things don't move so quickly in the pharmaceutical industry, and buying shares right now, right after a big run-up, may not be the optimal strategy for investors to make the most of the company's next attempts.

So let's take a look at what it's doing, how long it might take for those efforts to pay off, and what investors can do to profit.

Source Fool.com

Like: 0

NVO

Share